Ironwood Pharmaceuticals (IRWD) Leases (2016 - 2025)
Historic Leases for Ironwood Pharmaceuticals (IRWD) over the last 17 years, with Q3 2025 value amounting to $9.8 million.
- Ironwood Pharmaceuticals' Leases fell 1447.94% to $9.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.8 million, marking a year-over-year decrease of 1447.94%. This contributed to the annual value of $11.0 million for FY2024, which is 1237.88% down from last year.
- As of Q3 2025, Ironwood Pharmaceuticals' Leases stood at $9.8 million, which was down 1447.94% from $10.2 million recorded in Q2 2025.
- Ironwood Pharmaceuticals' 5-year Leases high stood at $16.3 million for Q1 2021, and its period low was $9.8 million during Q3 2025.
- For the 5-year period, Ironwood Pharmaceuticals' Leases averaged around $13.2 million, with its median value being $13.3 million (2023).
- Per our database at Business Quant, Ironwood Pharmaceuticals' Leases crashed by 669.46% in 2021 and then crashed by 1447.94% in 2025.
- Ironwood Pharmaceuticals' Leases (Quarter) stood at $15.4 million in 2021, then decreased by 8.64% to $14.0 million in 2022, then dropped by 10.25% to $12.6 million in 2023, then dropped by 12.38% to $11.0 million in 2024, then decreased by 11.36% to $9.8 million in 2025.
- Its Leases was $9.8 million in Q3 2025, compared to $10.2 million in Q2 2025 and $10.6 million in Q1 2025.